The fetal bovine serum market is expanding as biopharmaceutical research, cell-based studies, vaccine development, and advanced therapies increase demand for reliable cell culture supplements. The market was valued at USD 2.3 billion in 2025 and is projected to grow from USD 2.6 billion in 2026 to USD 6.9 billion by 2033, advancing at a CAGR of 14.5% from 2026 to 2033. North America accounted...